Israel - English - Ministry of Health

medison pharma ltd - anagrelide hydrochloride 0.5 mg - capsules - anagrelide - indicated for the treatment of patients with essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.

Philippines - English - FDA (Food And Drug Administration)

genasia biotech l.l. corp. - anagrelide (as hydrochloride) - capsule - 500mcg

Philippines - English - FDA (Food And Drug Administration)

globo asiatico enterprises inc.; distributor: globo asiatico enterprises inc. - anagrelide (as hydrochloride) - capsule - 500mcg

European Union - English - EMA (European Medicines Agency)

shire pharmaceuticals ireland limited - anagrelide - thrombocythemia, essential - antineoplastic agents, - xagrid is indicated for the reduction of elevated platelet counts in at-risk essential-thrombocythaemia (et) patients who are intolerant to their current therapy or whose elevated platelet counts are not reduced to an acceptable level by their current therapy. an at-risk patient an at-risk et is defined by one or more of the following features: >60 years of age or;, a platelet count >1000 x 109/l or;, a history of thrombohaemorrhagic events.,

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: torrent pharma philippines, inc.; distributor: torrent pharma philippines, inc. - anagrelide (as hydrochloride) - capsule - 500 mcg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: i.e. medica, inc.; distributor: i.e. medica, inc. - anagrelide (as hydrochloride) - tablet - 500 mcg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: i.e. medica, inc; distributor: i.e. medica, inc - anagrelide (as hydrochloride) - tablet - 500 mcg

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

takeda pharmaceutical company limited. - anagrelide hydrochloride hydrate - white hard capsule, major axis: approx. 14.3 mm, minor axis: approx. 5.32 mm